Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
3.19
↓ 100% below average
Average (6y)
4275.41
Historical baseline
Range
High:29924.69
Low:0.00
CAGR
-78.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 3.19 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | -100.0% |
| 2018 | 29924.69 | - |